Recombinant TGFB2 (Lerdelimumab Biosimilar) antibody
This Human Monoclonal antibody specifically detects TGFB2 (Lerdelimumab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597779
$350.96
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant TGFB2 (Lerdelimumab Biosimilar) antibody (ABIN7597779)
Target
TGFB2 (Lerdelimumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Lerdelimumab Biosimilar Antibody
-
Specificity
- Glioblastoma-derived T-cell suppressor factor, TGF-beta-2, LAP, G-TSF, TGFB2, Cetermin, Transforming growth factor beta-2 proprotein
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TGFB2 (Lerdelimumab Biosimilar)
-
Alternative Name
- Lerdelimumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Glioblastoma-derived T-cell suppressor factor, TGF-beta-2, LAP, G-TSF, TGFB2, Cetermin, Transforming growth factor beta-2 proprotein
-
UniProt
- P61812
-
CAS-No
- 285985-06-0
Target
-
You are here:
